Steatohepatitis/Metabolic Liver Disease

You have full text access to this OnlineOpen article

Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease†

  1. Winston Dunn1,
  2. Ronghui Xu2,
  3. Jeffrey B. Schwimmer3,‡,*

Article first published online: 21 FEB 2008

DOI: 10.1002/hep.22292

Issue

Hepatology

Hepatology

Volume 47, Issue 6, pages 1947–1954, June 2008

Additional Information

How to Cite

Dunn, W., Xu, R. and Schwimmer, J. B. (2008), Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology, 47: 1947–1954. doi: 10.1002/hep.22292

Author Information

  1. 1

    Division of Gastroenterology, Department of Medicine, University of California, San Diego, San Diego, CA

  2. 2

    Department of Family and Preventive Medicine and Department of Mathematics, University of California, San Diego, San Diego, CA

  3. 3

    Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego, San Diego, CA

  1. ‡

    fax: 619-543-7537

*Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego, 200 West Arbor Drive, San Diego, CA 92103-8450

  1. †

    Potential conflict of interest: The funders did not participate in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The authors have no financial conflicts of interest.

Publication History

  1. Issue published online: 28 MAY 2008
  2. Article first published online: 21 FEB 2008
  3. Accepted manuscript online: 21 FEB 2008 12:00AM EST
  4. Manuscript Accepted: 12 FEB 2008
  5. Manuscript Received: 7 NOV 2007

Funded by

  • National Institutes of Health (NIH)
  • National Research Service Award (NRSA). Grant Number: T32 DK07202
  • NIH National Center for Research Resources for the General Clinical Research Center at the University of California, San Diego (UCSD). Grant Number: M01 RR000827

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (154K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emma De Feo, Consuelo Cefalo, Dario Arzani, Rosarita Amore, Raffaele Landolfi, Antonio Grieco, Walter Ricciardi, Luca Miele, Stefania Boccia, A case–control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease, Molecular Biology Reports, 2012, 39, 7, 7381

    CrossRef

  2. You have free access to this content2
    A. Birerdinc, M. Stepanova, L. Pawloski, Z. M. Younossi, Caffeine is protective in patients with non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2012, 35, 1
    Direct Link:
  3. 3
    Peter Marks, Roger Williams, Calorie and alcohol consumption in nonalcoholic fatty liver disease, European Journal of Gastroenterology & Hepatology, 2012, 24, 5, 527

    CrossRef

  4. 4
    G. Musso, M. Cassader, F. Rosina, R. Gambino, Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials, Diabetologia, 2012, 55, 4, 885

    CrossRef

  5. 5
    Winston Dunn, Arun J. Sanyal, Elizabeth M. Brunt, Aynur Unalp-Arida, Michael Donohue, Arthur J. McCullough, Jeffrey B. Schwimmer, Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD), Journal of Hepatology, 2012,

    CrossRef

  6. 6
    E. Nova, G. C. Baccan, A. Veses, B. Zapatera, A. Marcos, Potential health benefits of moderate alcohol consumption: current perspectives in research, Proceedings of the Nutrition Society, 2012, 71, 02, 307

    CrossRef

  7. 7
    Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige, Kazuhisa Kodama, Tomomi Kogiso, Nobuyuki Torii, Keiko Shiratori, Roles of gender, obesity, and lifestyle-related diseases in alcoholic liver disease: Obesity does not influence the severity of alcoholic liver disease, Hepatology Research, 2012, 42, 4
    Direct Link:
  8. 8
    Naga Chalasani, Zobair Younossi, Joel E Lavine, Anna Mae Diehl, Elizabeth M Brunt, Kenneth Cusi, Michael Charlton, Arun J Sanyal, The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, The American Journal of Gastroenterology, 2012,

    CrossRef

  9. 9
    Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology, Gastroenterology, 2012, 142, 7, 1592

    CrossRef

  10. You have free access to this content10
    Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 2012, 55, 6
    Direct Link:
  11. 11
    A. Moriya, Y. Iwasaki, S. Ohguchi, E. Kayashima, T. Mitsumune, H. Taniguchi, F. Ikeda, Y. Shiratori, K. Yamamoto, Alcohol consumption appears to protect against non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2011, 33, 3
    Direct Link:
  12. 12
    Sunil Dogra, Rashmi Jindal, Cutaneous Manifestations of Common Liver Diseases, Journal of Clinical and Experimental Hepatology, 2011, 1, 3, 177

    CrossRef

  13. 13
    Karima Begriche, Julie Massart, Marie-Anne Robin, Annie Borgne-Sanchez, Bernard Fromenty, Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver, Journal of Hepatology, 2011, 54, 4, 773

    CrossRef

  14. 14
    Arun J. Sanyal, Elizabeth M. Brunt, David E. Kleiner, Kris V. Kowdley, Naga Chalasani, Joel E. Lavine, Vlad Ratziu, Arthur McCullough, Endpoints and clinical trial design for nonalcoholic steatohepatitis, Hepatology, 2011, 54, 1
    Direct Link:
  15. 15
    W. Nseir, A. Shalata, A. Marmor, N. Assy, Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease, Digestive Diseases and Sciences, 2011, 56, 12, 3439

    CrossRef

  16. 16
    Tohru Utsunomiya, Mitsuo Shimada, Molecular characteristics of non-cancerous liver tissue in non-B non-C hepatocellular carcinoma, Hepatology Research, 2011, 41, 8
    Direct Link:
  17. You have free access to this content17
    Edward Lebovics, Jonah Rubin, Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do, Diabetes/Metabolism Research and Reviews, 2011, 27, 5
    Direct Link:
  18. 18
    Melissa Palmer, Gastrointestinal and Liver Disease Nutrition Desk Reference, 2011,

    CrossRef

  19. 19
    Vlad Ratziu, Stefano Bellentani, Helena Cortez-Pinto, Chris Day, Giulio Marchesini, A position statement on NAFLD/NASH based on the EASL 2009 special conference, Journal of Hepatology, 2010, 53, 2, 372

    CrossRef

  20. 20
    Yasunari Hiramine, Yasushi Imamura, Hirofumi Uto, Chihaya Koriyama, Masahisa Horiuchi, Makoto Oketani, Kaori Hosoyamada, Ken Kusano, Akio Ido, Hirohito Tsubouchi, Alcohol drinking patterns and the risk of fatty liver in Japanese men, Journal of Gastroenterology, 2010, 46, 4, 519

    CrossRef

  21. 21
    Stephen Caldwell, Cryptogenic Cirrhosis: What Are We Missing?, Current Gastroenterology Reports, 2010, 12, 1, 40

    CrossRef

  22. 22
    Angel Brea Hernando, José Puzo Foncillas, Enfermedad del hígado graso no alcohólico y riesgo cardiovascular, Clínica e Investigación en Arteriosclerosis, 2010, 22, 6, 259

    CrossRef

  23. 23
    G. Musso, R. Gambino, M. Cassader, Non-alcoholic fatty liver disease from pathogenesis to management: an update, Obesity Reviews, 2010, 11, 6
    Direct Link:
  24. 24
    P. Loria, L.E. Adinolfi, S. Bellentani, E. Bugianesi, A. Grieco, S. Fargion, A. Gasbarrini, C. Loguercio, A. Lonardo, G. Marchesini, F. Marra, M. Persico, D. Prati, G. Svegliati- Baroni, Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease, Digestive and Liver Disease, 2010, 42, 4, 272

    CrossRef

  25. 25
    Llorenç Caballería, Guillem Pera, Maria Antònia Auladell, Pere Torán, Laura Muñoz, Dolores Miranda, Alba Alumà, José Dario Casas, Carmen Sánchez, Dolors Gil, Josep Aubà, Albert Tibau, Santiago Canut, Jesús Bernad, Miren Maite Aizpurua, Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain, European Journal of Gastroenterology & Hepatology, 2010, 22, 1, 24

    CrossRef

  26. 26
    Toshiaki Gunji, Nobuyuki Matsuhashi, Hajime Sato, Kimiko Iijima, Kazutoshi Fujibayashi, Mitsue Okumura, Noriko Sasabe, Akio Urabe, Risk factors for serum alanine aminotransferase elevation: A cross-sectional study of healthy adult males in Tokyo, Japan, Digestive and Liver Disease, 2010, 42, 12, 882

    CrossRef

  27. 27
    Tamaki Yamada, Mitsuru Fukatsu, Sadao Suzuki, Takashi Yoshida, Shinkan Tokudome, Takashi Joh, Alcohol Drinking May Not Be a Major Risk Factor for Fatty Liver in Japanese Undergoing a Health Checkup, Digestive Diseases and Sciences, 2009, 55, 1, 176

    CrossRef

  28. 28
    T. Berg, Diagnostik bei erhöhten Leberwerten, Der Gastroenterologe, 2009, 4, 6, 557

    CrossRef

  29. 29
    Helma P. Cotrim, Luiz Antônio Freitas, Erivaldo Alves, Alessandro Almeida, Daniel S. May, Stephen Caldwell, Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients, European Journal of Gastroenterology & Hepatology, 2009, 21, 9, 969

    CrossRef

  30. 30
    Toshiaki Gunji, Nobuyuki Matsuhashi, Hajime Sato, Kazutoshi Fujibayashi, Mitsue Okumura, Noriko Sasabe, Akio Urabe, Light and Moderate Alcohol Consumption Significantly Reduces the Prevalence of Fatty Liver in the Japanese Male Population, The American Journal of Gastroenterology, 2009, 104, 9, 2189

    CrossRef

  31. 31
    Karima Begriche, Laetitia Knockaert, Julie Massart, Marie-Anne Robin, Bernard Fromenty, Mitochondrial dysfunction in nonalcoholic steatohepatitis (NASH): are there drugs able to improve it?, Drug Discovery Today: Disease Mechanisms, 2009, 6, 1-4, e11

    CrossRef

  32. 32
    Raj Vuppalanchi, Naga Chalasani, Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management, Hepatology, 2009, 49, 1
    Direct Link:
  33. 33
    Moderate wine drinking might decrease prevalence of nonalcoholic fatty liver disease, Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5, 9, 478

    CrossRef

  34. 34
    Winston Dunn, Jeffrey B. Schwimmer, Reply:, Hepatology, 2008, 48, 3
    Direct Link:
  35. 35
    Margaret S Sozio, Naga Chalasani, Suthat Liangpunsakul, What advice should be given to patients with NAFLD about the consumption of alcohol?, Nature Clinical Practice Gastroenterology & Hepatology, 2008, 6, 1, 18

    CrossRef

  36. 36
    Tetsuji Fujita, Who is benefited by one daily glass of wine?, Hepatology, 2008, 48, 3
    Direct Link:
  37. 37
    Christopher P Day, Non-Alcoholic Fatty Liver Disease,
    Direct Link:
  38. 38
    Stephen H. Caldwell, Curtis K. Argo, Non-Alcoholic Fatty Liver Disease and Nutrition,
    Direct Link:
View Full Article (HTML) Get PDF (154K)